Profitability Metrics

Gross Margin
68.92%
Operating Margin
29.20%
Net Margin
18.79%

Efficiency Metrics

Revenue per Expense Ratio
1.41
R&D as % of Revenue
0.00%

Earnings Quality

EBITDA Margin
60.74%
Income Tax Rate
0.00%
EPS
1.8000000000

Balance Sheet Analysis

Current Ratio
1.86
Cash Ratio
1.15
Working Capital
$591.33M
Debt to Equity
0.93
Debt to Assets
44.32%
Equity Ratio
47.61%

Cash Flow Analysis

Operating Cash Flow Ratio
53.34%
Free Cash Flow Ratio
5.20%
CapEx to Revenue
48.14%
Dividends Paid
$255.43M
Stock Buybacks
$11.60M
Total Shareholder Returns
$267.03M
Cash Position Change
46.86%

Key Takeaways (2023 FY)

  • Maintained positive net income growth despite revenue changes
  • Increased dividend payments by 2.87%

Detailed Growth Metrics

Core Performance

Revenue
2.98%
Net Income
21.13%
EPS
20.00%
Operating Income
1.06%

Operational Efficiency

R&D Expenses
-100.00%
SG&A Expenses
-0.22%
Operating Cash Flow
1.75%
Free Cash Flow
944.61%

Balance Sheet Health

Assets
5.59%
Debt
15.15%
Book Value per Share
-0.57%
Inventory
100.00%

Shareholder Returns

Dividends per Share
2.87%
Shares Outstanding
0.30%

Long Term Trends

3Y Revenue/Share
21.54%
5Y Revenue/Share
28.99%
3Y Dividend/Share
9.93%
5Y Dividend/Share
21.48%